BioRestorative Therapies, Inc. (BRTX) stock
BRTXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
$1.34−0.08 (-5.63%)
Close on Nov 17, 2026Market cap $34.14MP/E –Yield –
BioRestorative Therapies price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
BioRestorative Therapies's price to sales ratio was 111.1× on Nov 11, 2026, against 382.3× a year earlier. Over the last 4 years it ranged from 1.2× to 493.3×, with a median of 49.7×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 111.1× | −377.9 |
| 2025 | Dec 31, 2025 | 489.0× | +438.8 |
| 2020 | Jul 31, 2020 | 50.2× | +31.6 |
| 2019 | Dec 31, 2019 | 18.7× | −407.9 |
| 2016 | Apr 29, 2016 | 426.6× | −49.9 |
| 2015 | Dec 31, 2015 | 476.4× | +434.9 |
| 2014 | Dec 31, 2014 | 41.5× | +22.5 |
| 2013 | Apr 12, 2013 | 19.1× | −8.0 |
| 2012 | Dec 27, 2012 | 27.1× | – |
See a number that looks wrong?